135 related articles for article (PubMed ID: 22258929)
21. CpG and poly(I:C) stimulation of dendritic cells and fibroblasts limits herpes simplex virus type 1 infection in an IFNβ-dependent and -independent way.
Gaajetaan GR; Geelen TH; Grauls GE; Bruggeman CA; Stassen FR
Antiviral Res; 2012 Jan; 93(1):39-47. PubMed ID: 22057305
[TBL] [Abstract][Full Text] [Related]
22. The role of toll-like receptors in host defenses and their relevance to dermatologic diseases.
Terhorst D; Kalali BN; Ollert M; Ring J; Mempel M
Am J Clin Dermatol; 2010; 11(1):1-10. PubMed ID: 20000870
[TBL] [Abstract][Full Text] [Related]
23. Antiviral signaling through pattern recognition receptors.
Kawai T; Akira S
J Biochem; 2007 Feb; 141(2):137-45. PubMed ID: 17190786
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic applications of nucleic acids as ligands for Toll-like receptors.
Panter G; Kuznik A; Jerala R
Curr Opin Mol Ther; 2009 Apr; 11(2):133-45. PubMed ID: 19330719
[TBL] [Abstract][Full Text] [Related]
25. Viruses and interferon: a fight for supremacy.
Katze MG; He Y; Gale M
Nat Rev Immunol; 2002 Sep; 2(9):675-87. PubMed ID: 12209136
[TBL] [Abstract][Full Text] [Related]
26. Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response.
Oganesyan G; Saha SK; Guo B; He JQ; Shahangian A; Zarnegar B; Perry A; Cheng G
Nature; 2006 Jan; 439(7073):208-11. PubMed ID: 16306936
[TBL] [Abstract][Full Text] [Related]
27. The role of Toll-like receptors in the host response to viruses.
Bowie AG; Haga IR
Mol Immunol; 2005 May; 42(8):859-67. PubMed ID: 15829275
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists.
Kanzler H; Barrat FJ; Hessel EM; Coffman RL
Nat Med; 2007 May; 13(5):552-9. PubMed ID: 17479101
[TBL] [Abstract][Full Text] [Related]
29. Viral recognition by Toll-like receptors.
Barton GM
Semin Immunol; 2007 Feb; 19(1):33-40. PubMed ID: 17336545
[TBL] [Abstract][Full Text] [Related]
30. TLRs as pharmacological targets for plant-derived compounds in infectious and inflammatory diseases.
Liu X; Zheng J; Zhou H
Int Immunopharmacol; 2011 Oct; 11(10):1451-6. PubMed ID: 21586344
[TBL] [Abstract][Full Text] [Related]
31. TLR based therapeutics.
Dunne A; Marshall NA; Mills KH
Curr Opin Pharmacol; 2011 Aug; 11(4):404-11. PubMed ID: 21501972
[TBL] [Abstract][Full Text] [Related]
32. [The first answer to viral infections: type I interferon].
Pichlmair A; Pollak M; Bergthaler A
Berl Munch Tierarztl Wochenschr; 2004; 117(7-8):252-65. PubMed ID: 15298051
[TBL] [Abstract][Full Text] [Related]
33. Regulators of innate immunity as novel targets for panviral therapeutics.
Es-Saad S; Tremblay N; Baril M; Lamarre D
Curr Opin Virol; 2012 Oct; 2(5):622-8. PubMed ID: 23017246
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms of interferon mediated anti-viral resistance.
Clarke CJ; Trapani JA; Johnstone RW
Curr Drug Targets Immune Endocr Metabol Disord; 2001 Aug; 1(2):117-30. PubMed ID: 12476793
[TBL] [Abstract][Full Text] [Related]
35. Essential viral and cellular zinc and iron containing metalloproteins as targets for novel antiviral and anticancer agents: implications for prevention and therapy of viral diseases and cancer.
Fernandez-Pol JA; Hamilton PD; Klos DJ
Anticancer Res; 2001; 21(2A):931-57. PubMed ID: 11396187
[TBL] [Abstract][Full Text] [Related]
36. [Toll-like receptors, a new way of treatment?].
Pedersen CV; Østergaard LJ; Mogensen TH; Paludan SR; Bertelsen LS
Ugeskr Laeger; 2007 Jun; 169(23):2193-8. PubMed ID: 17592684
[TBL] [Abstract][Full Text] [Related]
37. Recognition of viral nucleic acids in innate immunity.
Yoneyama M; Fujita T
Rev Med Virol; 2010 Jan; 20(1):4-22. PubMed ID: 20041442
[TBL] [Abstract][Full Text] [Related]
38. Toll like receptors and viruses.
Finberg RW; Wang JP; Kurt-Jones EA
Rev Med Virol; 2007; 17(1):35-43. PubMed ID: 17146842
[TBL] [Abstract][Full Text] [Related]
39. Profile of Toll-like receptor expressions and induction of nitric oxide synthesis by Toll-like receptor agonists in chicken monocytes.
He H; Genovese KJ; Nisbet DJ; Kogut MH
Mol Immunol; 2006 Mar; 43(7):783-9. PubMed ID: 16098593
[TBL] [Abstract][Full Text] [Related]
40. Physiological Proteins in Therapeutics: A Current Review on Interferons.
Ghosh D; Ghosh D; Parida P
Mini Rev Med Chem; 2016; 16(12):947-52. PubMed ID: 27499189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
